Interviews - Part 2

Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

59459 1490631916HCLSReviewIrelandMarch2017.pdf
Energy Boardroom

Pharma Interviews


Filter

1

Interview: Guillaume Corpart – Founder & Managing Director, Global Health Intelligence, Mexico

The founder and Managing Director of Global Health Intelligence (GHI), Guillaume Corpart highlights the value of competitive intelligence for medical device companies looking to either enter emerging healthcare markets in Latin America and Asia or identify new market opportunities. As …

24.03.2017

Mark Griffiths -Global CEO - Dishman Groug

Interview: Mark Griffiths – Group CEO, Dishman Group

“Get it done! That is what CARBOGEN AMCIS is all about!” – The CEO of the Swiss drug development and commercialization services company elaborates on the company’s strong mindset and declares customer intimacy to be their unique selling point. CARBOGEN …

24.03.2017


1

Interview: Aristides Torres – CEO, Laboratorios Vanquish, Mexico

Aristides Torres, CEO at Laboratorios Vanquish, explains how the company has evolved during the last five years to serve both the public and private markets and why they have focused on niche market areas with high unmet patient need. Could …

24.03.2017

1

Interview: Jui-Lin Chen PhD – CEO, MiCareo, Taiwan

Jui-Lin Chen, CEO of MiCareo, provides insights into the development of MiSelect, Micareo’s pioneering platform for the analysis of Circulating Tumor Cells (CTC) and other rare cells, which proudly stands as the best product available to physicians for cancer prognosis …

24.03.2017


Untitled

Interview: Sergio Olivares – Managing Director, Olivares, Mexico

Sergio Olivares, managing director at Olivares, explains the TPP’s impact on the Mexican pharmaceutical industry’s dynamism and Olivares’ business proposal as a one-stop shop solution to fulfill all its current and future clients’ intellectual property needs. Olivares began as an …

23.03.2017

Untitled

Interview: Raymond Cron – CEO, Switzerland Innovation

The most innovative country in the world must constantly launch new initiatives to attract R&D activities if that lead is to be maintained, and Switzerland Innovation is doing just that – by showcasing the opportunities that the Swiss Innovation Park …

23.03.2017


1

Interview: Mario Amadio – President & CEO, GE Healthcare Mexico

“Equipment is not everything that GE can contribute with!” – The CEO and President of GE Healthcare’s Mexican Unit elaborates on how GE provides added value to its customers by focusing on innovating access, cost and quality. With what mission …

23.03.2017

Thomas Bohn - GGBa

Interview: Thomas Bohn – Executive Director, Greater Geneva Bern area (GGBa), Switzerland

The Executive Director of the Greater Geneva Bern area, Western Switzerland’s investment promotion agency, elaborates on the unique assets the region has to offer, and highlights the strong pro-business mindset of the Swiss people. Could you please start by elaborating …

23.03.2017


Thomas A. Tóth von Kiskér - CEO - Tillotts Pharma AG

Interview: Thomas A. Tóth von Kiskér – CEO, Tillotts Pharma, Switzerland

Backed by the Japanese Zeria Group, fast growing gastrointestinal (GI) specialist Tillotts Pharma is looking to acquire further GI assets after its recent USD 200m M&A deal. The company is looking for assets which generate a turnover of EUR 50 …

23.03.2017

Arturo Rodriguez, director general of Infinite Clinical Research and President of ACROM

Interview: Arturo Rodríguez Jacob – CEO, Infinite Clinical Research; President, ACROM, Mexico

Arturo Rodríguez Jacob, CEO at Infinite Clinical Research (ICR) and president of the national association of CROs (ACROM), explains what make Mexico the regional clinical research hub and showcases how ICR is developing clinical studies for allopathic, biotech, medtech, and …

22.03.2017


1

Interview: Chen Min-Che – Founder & Managing Director, Asclepiumm, Taiwan

Chen Min-Che, founder and managing director of Asclepiumm, provides insights into the main milestones reached and the new partnership opportunities considered by this exciting biotech company, whose Antibody Switch-on Cytotoxicity (ASC) technology platform could contribute to bringing onto the global …

22.03.2017

Prof Luca Guidotti

Interview: Luca G. Guidotti – Deputy Scientific Director, San Raffaele Scientific Institute (SRSI), Italy

Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community, their core mission of translational medicine and the challenges Italy faces today with the development of young scientific talent and the bridging of the …

22.03.2017


Cover_HCLS_Ireland LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: